References
- Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007;41:1992-2001. https://doi.org/10.1345/aph.1K302
- Pearlman E. Pathogenesis and immunity in helminthic infection. In: Mahmoud AA, editor. Parasitic lung diseases. New York: Marcel Dekker; 1997. p. 33-46.
- Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;17:208-17. https://doi.org/10.1128/CMR.17.1.208-217.2004
- Weller PF. Eosinophilia and eosinophil-related disorders. In: Adkinson NF Jr, Busse WW, Bochner BS, Holgate ST, Simons FE, Lemanske RF Jr, editors. Middleton's allergy: principles & practice. 7th ed. Philadelphia: Mosby; 2009. p. 859-77.
- Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-7. https://doi.org/10.1086/322707
- Wehner JH, Kirsch CM. Pulmonary manifestations of strongyloidiasis. Semin Respir Infect 1997;12:122-9.
- Mahmoud AA. Strongyloidiasis. Clin Infect Dis 1996;23:949-52. https://doi.org/10.1093/clinids/23.5.949
- Fishman JA. Helminthic diseases of the lungs. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, editors. Fishman's pulmonary diseases and disorders. 4th ed. New York: McGraw-Hill; 2008. p. 2413- 26.
- Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Paterson BR, Walker PF. Strongyloides hyperinfection presenting as acute respiratory failure and gram negative sepsis. Chest 2005;128:3681-4. https://doi.org/10.1378/chest.128.5.3681
- Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's gastrointestinal and liver disease. 7th ed. Philadelphia: W.B. Saunders; 2002. p. 1954-5.
- Wilson ME, Weller PF. Eosinophilia. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogenesis, and practice. 2nd ed. Philadelphia: Churchill Livingstone; 2006. p. 1478-95.
- Savage D, Foadi M, Haworth C, Grant A. Marked eosinophilia in an immunosuppressed patient with strongyloidiasis. J Intern Med 1994;236:473-5. https://doi.org/10.1111/j.1365-2796.1994.tb00828.x
- Gill GV, Bailey JW. Eosinophilia as a marker for chronic strongyloidiasis: use of a serum ELISA test to detect asymptomatic cases. Ann Trop Med Parasitol 1989;83:249-52. https://doi.org/10.1080/00034983.1989.11812339
- Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sanchez-Sanchez P, Matogo-Oyana J, Rodriguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother 2004;5:2615-9. https://doi.org/10.1517/14656566.5.12.2615
- Satoh M, Kokaze A. Treatment strategies in controlling strongyloidiasis. Expert Opin Pharmacother 2004;5:2293-301. https://doi.org/10.1517/14656566.5.11.2293
Cited by
- A Case of Steroid-induced Hyperinfective Strongyloidiasis with Bacterial Meningitis vol.60, pp.5, 2012, https://doi.org/10.4166/kjg.2012.60.5.330